Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Masimo ( (MASI) ) has provided an update.
On November 4, 2025, Masimo Corporation announced its financial results for the third quarter of 2025, reporting a GAAP revenue of $371.5 million, an 8.2% increase, and a non-GAAP net income per diluted share growth of 38% compared to the previous year. The company highlighted its strategic moves, including the sale of Sound United and an expanded partnership with Philips, positioning itself for sustainable long-term growth.
The most recent analyst rating on (MASI) stock is a Hold with a $152.00 price target. To see the full list of analyst forecasts on Masimo stock, see the MASI Stock Forecast page.
Spark’s Take on MASI Stock
According to Spark, TipRanks’ AI Analyst, MASI is a Neutral.
Masimo’s overall stock score reflects a mix of financial challenges and positive strategic initiatives. The most significant factor is the company’s financial performance, which shows declining revenue and profitability, impacting the score negatively. However, the positive earnings call, with strong revenue growth and strategic focus on innovation, provides a counterbalance. Technical analysis and valuation also contribute to the score, but to a lesser extent.
To see Spark’s full report on MASI stock, click here.
More about Masimo
Masimo Corporation operates in the healthcare industry, focusing on innovative medical technologies. The company is known for its noninvasive monitoring technologies, which are used in hospitals and other healthcare settings to improve patient care and safety.
Average Trading Volume: 717,108
Technical Sentiment Signal: Sell
Current Market Cap: $7.87B
See more data about MASI stock on TipRanks’ Stock Analysis page.